<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Leeuwen, M. van</title>
    <link>http://repub.eur.nl/res/aut/15308/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Human astrovirus infection in a patient with new-onset celiac disease (Article)</title>
      <link>http://repub.eur.nl/res/pub/27502/</link>
      <pubDate>2010-09-01T00:00:00Z</pubDate>
      <description>Many diseases with unknown etiology may be caused by unidentified viruses. Sequence-independent amplification revealed a new astrovirus, similar to VA1, in a 4-year-old male diagnosed with celiac disease. This expands the geographic range of this virus to include Europe and may associate astrovirus infection with the onset of celiac disease. Copyright </description>
    </item> <item>
      <title>Human picobirnaviruses identified by molecular screening of diarrhea samples (Article)</title>
      <link>http://repub.eur.nl/res/pub/27673/</link>
      <pubDate>2010-05-01T00:00:00Z</pubDate>
      <description>The global threat of (re)emerging infectious viruses requires a more effective approach regarding virus surveillance and diagnostic assays, as current diagnostics are often virus species specific and not able to detect highly divergent or unknown viruses. A systematic exploration of viruses that infect humans is the key to effectively counter the potential public health threat caused by new and emerging infectious diseases. The human gut is a known reservoir of a wide variety of microorganisms, including viruses. In this study, Dutch clinical diarrhea samples for which no etiological agent could be identified by available cell culture, serological, or nucleic acid-based tests were gathered. Large-scale molecular RNA virus screening based on host nucleic acid depletion, sequence-independent amplification, and sequencing of partially purified viral RNA from a limited number of clinical diarrhea samples revealed four eukaryotic virus species. Among the detected viruses were a rhinovirus and a new picobirnavirus variant. In total, ∼20% of clinical diarrhea samples contained human picobirnavirus sequences. The Dutch picobirnaviruses belonged to different phylogenetic clades and did not group with other picobirnaviruses according to year of isolation or host species. Interestingly, the average age of patients infected with picobirnavirus was significantly higher than that of uninfected patients. Our data show that sequence-independent amplification of partially purified viral RNA is an efficient procedure for identification of known and highly divergent new RNA viruses in clinical diarrhea samples. Copyright </description>
    </item> <item>
      <title>Attention Problems, Inhibitory Control, and Intelligence Index Overlapping Genetic Factors: A Study in 9-, 12-, and 18-Year-Old Twins (Article)</title>
      <link>http://repub.eur.nl/res/pub/16396/</link>
      <pubDate>2009-05-01T00:00:00Z</pubDate>
      <description>It is assumed that attention problems (AP) are related to impaired executive functioning. We investigated the association between AP and inhibitory control and tested to what extent the association was due to genetic factors shared with IQ. Data were available from 3 independent samples of 9-, 12-, and 18-year-old twins and their siblings (1,209 participants). AP were assessed with checklists completed by multiple informants. Inhibitory control was measured with the Stroop Color Word Task (Stroop, 1935), and IQ with the Wechsler Intelligence Scale for Children (Wechsler et al., 2002) or Wechsler Adult Intelligence Scale (Wechsler, 1997). AP and inhibitory control were only correlated in the 12-year-old cohort (r = .18), but appeared non-significant after controlling for IQ. Significant correlations existed between AP and IQ in 9- and 12-year olds (r = -.26/-.34). Inhibitory control and IQ were correlated in all cohorts (r = -.16, -.24 and -.35, respectively). Genetic factors that influenced IQ also influenced inhibitory control. We conclude that the association between AP and inhibitory control as reported in the literature may largely derive from genetic factors that are shared with IQ.</description>
    </item> <item>
      <title>Upstream Stimulatory Factors 1 and 2 activate the human hepatic lipase promoter via E-box dependent and independent mechanisms (Article)</title>
      <link>http://repub.eur.nl/res/pub/24285/</link>
      <pubDate>2009-04-01T00:00:00Z</pubDate>
      <description>We studied the transcriptional regulation of the HL gene by USF1 and USF2 in HepG2 cells. The transcriptional activity of the HL(- 685/+ 13) promoter construct was increased up to 25-fold by co-transfection with USF1 and USF2. Silencing of USF1 by RNA interference reduced promoter activity by 30-40%. Chromatin immunoprecipitation assays showed binding of endogenous USF1 and USF2 to the proximal HL promoter region. In gel shift assays, USF1 and USF2 bound to E-boxes at - 307/- 312 and - 510/- 516, and to the TATA-Inr region. Although the - 514C → T substitution abolished in vitro USF binding to the - 510/- 516 E-box, the increase in HL promoter activity by USF1 and USF2 was unaffected. Deletion and mutation analysis of the HL promoter region, and insertion of multiple E-box copies in front of a heterologous promoter, revealed that upregulation by USFs was mainly mediated through the - 307/- 312 E-box and the TATA-Inr region. We conclude that in HepG2 cells USF1 and USF2 regulate transcriptional activity of the HL gene through their binding to the E-box at - 307/- 312 and the TATA-Inr region. </description>
    </item> <item>
      <title>A novel mutation F826L in the human androgen receptor in partial androgen insensitivity syndrome; increased NH2-/COOH-terminal domain interaction and TIF2 co-activation (Article)</title>
      <link>http://repub.eur.nl/res/pub/29654/</link>
      <pubDate>2008-09-24T00:00:00Z</pubDate>
      <description>A novel mutation F826L located within the ligand binding domain (LBD) of the human androgen receptor (AR) was investigated. This mutation was found in a boy with severe penoscrotal hypospadias (classified as 46,XY DSD). The AR mutant F826L appeared to be indistinguishable from the wild-type AR, with respect to ligand binding affinity, transcriptional activation of MMTV-luciferase and ARE2-TATA-luciferase reporter genes, protein level in genital skin fibroblasts (GSFs), and sub-cellular distribution in transfected cells. However, an at least two-fold higher NH2-/COOH-terminal domain interaction was found in luciferase and GST pull-down assays. A two-fold increase was also observed for TIF2 (transcription intermediary factor 2) co-activation of the AR F826L COOH-terminal domain. This increase could not be explained by a higher stability of the mutant protein, which was within wild-type range. Repression of transactivation by the nuclear receptor co-repressor (N-CoR) was not affected by the AR F826L mutation. The observed properties of AR F826L would be in agreement with an increased activity rather than with a partial defective AR transcriptional activation. It is concluded that the penoscrotal hypospadias in the present case is caused by an as yet unknown mechanism, which still may involve the mutant AR. </description>
    </item> <item>
      <title>Functional analysis of a novel androgen receptor mutation, Q902K, in an individual with partial androgen insensitivity. (Article)</title>
      <link>http://repub.eur.nl/res/pub/13522/</link>
      <pubDate>2005-01-01T00:00:00Z</pubDate>
      <description>Androgen insensitivity syndrome (AIS) is caused by defects in the androgen
      receptor (AR) that render the AR partially or completely inactive. As a
      result, embryonic sex differentiation is impaired. Here, we describe a
      novel mutation in the AR found in a patient with partial AIS. The mutation
      results in a substitution of a glutamine (Q) by a lysine (K) residue at
      position 902, Q902K. The AR Q902K mutation was investigated in vitro with
      respect to its functional properties. The equilibrium dissociation
      constants (K(d)s) of AR Q902K in the presence of either the synthetic
      androgen R1881 or the natural ligand DHT were slightly elevated. The R1881
      dissociation rate (t(1/2)) was increased 3-fold for AR Q902K compared with
      wild type. Transcriptional activity was decreased to 85% of wild type, and
      the dose-response curve revealed that the sensitivity to hormone was
      decreased due to the mutation. Furthermore, the 114-kDa androgen-induced
      phosphorylated AR protein band was not detectable in genital skin
      fibroblasts. However, it could be detected in transfected CHO cells
      expressing the mutant receptor in the presence of 10 and 100 nm R1881.
      Functional interaction assays and a GST pull-down assay showed that the
      interaction between the NH2 and COOH terminus of AR Q902K was reduced to
      50% of wild type. Furthermore, the transactivation by the coactivator TIF2
      (transcriptional intermediary factor 2) was decreased 2- to 3-fold. The
      half-maximal response in both assays was shifted to a higher hormone
      concentration compared with wild type. These results indicate that residue
      Q902 is involved in TIF2 and NH2/COOH interaction and that the Q to K
      mutation results in a mild impairment of AR function, which can explain
      the partial AIS phenotype of the patient.</description>
    </item> <item>
      <title>Phosphorylation of androgen receptor isoforms (Article)</title>
      <link>http://repub.eur.nl/res/pub/13437/</link>
      <pubDate>2004-10-15T00:00:00Z</pubDate>
      <description>Phosphorylation of the human AR (androgen receptor) is directly correlated with the appearance of at least three AR isoforms on an SDS/polyacrylamide gel. However, it is still not clear to what extent phosphorylation is involved in the occurrence of isoforms, which sites are phosphorylated and what are the functions of these phosphosites. The human AR was expressed in COS-1 cells and AR phosphorylation was studied further by mutational analyses and by using reversed-phase HPLC and MS. The reversed-phase HPLC elution pattern of the three isoforms revealed that Ser-650 was phosphorylated constitutively. After de novo synthesis, only Ser-650 was phosphorylated in the smallest isoform of 110 kDa and both Ser-650 and Ser-94 were phosphorylated in the second isoform of 112 kDa. The hormone-induced 114 kDa isoform shows an overall increase in phosphorylation of all the isolated peptides. The activities of the Ser-Ala substitution mutant S650A (Ser-650--&gt;Ala) was found to be identical with wild-type AR activation in four different cell lines and three different functional analyses, e.g. transactivation, N- and C-terminal-domain interaction and co-activation by transcriptional intermediary factor 2. This was also found for mutants S94A and S515A with respect to transactivation. However, the S515A mutation, which should eliminate phosphorylation of the potential mitogen-activated protein kinase site, Ser-515, resulted in an unphosphorylated form of the peptide containing Ser-650. This suggests that Ser-515 can modulate phosphorylation at another site. The present study shows that the AR isoform pattern from AR de novo synthesis is directly linked to differential phosphorylation of a distinct set of sites. After mutagenesis of these sites, no major change in functional activity of the AR was observed.</description>
    </item>
  </channel>
</rss>